The latest updates from AFAR.
On February 1, The New York Times reported on two new studies led by AFAR grantees that appear to settle the question of whether Alzheimer's disease progresses through the brain by cell-to-cell transmission or because of variations in the inherent susceptibility of different areas of the brain to the processes of the disease. The studies, led by Scott A. Small, MD, and Karen Duff, PhD, (Columbia University Medical Center), and Bradley T. Hyman, MD, PhD, (Massachusetts General Hospital and Harvard Medical School), used mice genetically engineered to produce the human tau protein characteristic of neuron death in Alzheimer's. Although…